Tag Archives: Oregon

Hasenin Al-khersan Named 2016 Koch Kellan Scholar

Hasenin Al-khersan

PORTLAND, Ore., April 18, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., announced today that Hasenin Al-khersan has been named its 2016 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.

"The underlying principle of the Koch Kellan Scholarship is to cultivate educational opportunities and success for the next generation of ophthalmic leaders," stated Patrick Witham, President & CEO of Paragon BioTeck. "An enduring tribute to the professional lives of Doctors Koch and Kellan, it is a realization of Paragon's fundamental mission to continually elevate the standard of eye care. We do this by recognizing the talents and commitments of rising doctors such as Hasenin Al-khersan."

Hasenin Al-khersan is a third-year student at the University of Chicago Pritzker School of Medicine. As an adolescent, Mr. Al-khersan accompanied his grandmother to her glaucoma appointments, serving as a translator; later, he deepened his ophthalmic interests through cataract and glaucoma research and volunteering as the leader of Sight Savers, an international charity providing ophthalmic care in developing nations.

Upon receipt of the award, Mr. Al-khersan remarked that "Ophthalmology has long been more than an intellectual endeavor, but also a personal passion. To be recognized in this pursuit by Paragon BioTeck is humbling. I plan to continue my work in the field with Drs. Koch and Kellan; they are true examples of the impact that I may one day hope to make."

Mr. Al-khersan will join Scholarship namesakes and other distinguished industry leaders at the American Society of Cataract and Refractive Surgery annual meeting in New Orleans from May 6-8. There, he will be formally presented with the award.

About Paragon Gives and the Koch Kellan Scholarship:

Paragon Gives, a Paragon BioTeck, Inc., initiative, supports a number of charities and organizations, including those within the biotechnology and health care arena. The initiative also works with individuals and organizations that have made a positive impact on our customers, vendors, investors and industry as a whole.

The Koch Kellan Scholarship affirms Paragon's commitment to elevating the standard of eye care and enhancing patient quality of life. It was first awarded to Captain Edward Woodward of the University of South Florida Morsani College of Medicine, whose compelling personal connection to the field made him the ideal inaugural recipient.

About Paragon BioTeck, Inc.:

Paragon BioTeck, Inc., is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon BioTeck's portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes.

For more information about Paragon BioTeck, please visit http://www.paragonbioteck.com/.

Join the conversation on Facebook at https://www.facebook.com/ParagonBioTeck/ and on Twitter at @ParagonBioTeck.

* PHOTO for media: Send2Press.com/mediaboom/16-0418-hasenin-al-khersan-300dpi.jpg

* LOGO: Send2Press.com/mediaboom/16-0418-paragonbio-300dpi.jpg

MEDIA CONTACT:
Michael Elofer
484-620-6167
mike@pascalecommunications.com

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/hasenin-al-khersan-named-2016-koch-kellan-scholar-2016-0418-02.shtml.

NEWS SOURCE Paragon BioTeck, Inc. :: This press release was issued on behalf of the news source (who is solely responsible for its accuracy) by and Copr. © 2016 Send2Press® Newswire, a service of Neotrope®.

Paragon BioTeck Receives EN ISO 13485:2012 Certification

medical devices

PORTLAND, Ore., March 29, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today that it has received EN ISO 13485:2012 certification, signifying the company's successful implementation of an effective quality management system.

The EN ISO 13485:2012 certification was awarded by the International Organization for Standardization, the world's largest developer and publisher of global quality and safety standards. This certification outlines specific requirements to establish and execute a structured quality management system for medical devices across all areas, from development to supply.

"Achieving this certification is an important milestone for Paragon BioTeck," said Lauren M-C Bluett, Director of Quality Assurance. "We have implemented a robust quality management system that conforms to ISO's global standards, demonstrating our commitment to excellence in product and operations through continuous improvement and quality by design."

Receipt of this certification paves the way for continued advancement of quality systems that meet world-class standards and maintain a central focus on patient safety and care.

About Paragon BioTeck, Inc.:

Paragon BioTeck, Inc., is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon BioTeck's portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes.

These products include the Comfortear(R) Lacrisolve(TM) 180 Absorbable Punctum Plug, Comfortear(R) Punctum Plug, EqualEyes(R) Ocular Lubricant, the preservative-free ilast(R) range of products and their FDA-approved Phenylephrine Hydrochloride Ophthalmic Solution USP, available in 2.5% and 10%.

For more information about Paragon BioTeck and its products, please visit http://www.paragonbioteck.com/.

Join the conversation on Facebook ( https://www.facebook.com/ParagonBioTeck/ ) and Twitter: @ParagonBioTeck.

* LOGO for media: Send2Press.com/mediaboom/16-0329-paragonbio-300dpi.jpg

MEDIA CONTACT:
Michael Elofer
mike@pascalecommunications.com
(484) 620-6167

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/paragon-bioteck-receives-en-iso-13485-2012-certification-2016-0329-02.shtml.

NEWS SOURCE Paragon BioTeck, Inc. :: This press release was issued on behalf of the news source (who is solely responsible for its accuracy) by and Copr. © 2016 Send2Press® Newswire, a service of Neotrope®.

Erin Brockovich and Weitz & Luxenberg Responding to Air Quality Issues in Portland, Oregon

environmental activist

NEW YORK, N.Y., Feb. 26, 2016 (SEND2PRESS NEWSWIRE) -- Long-time environmental activist Erin Brockovich is joining with Weitz & Luxenberg, P.C., attorney Robin Greenwald to investigate claims from Portland, Oregon area residents who may have been harmed by chemical emissions released into the air by art-glass companies in the region.

Public Health Emergency Due to Chemical Emissions:

In early February, Oregon officials notified the public that scientists had detected exceptionally high levels of the toxic metals arsenic and cadmium in specific areas, or hotspots, of Portland.

According to news sources, the level of arsenic was 159 times greater than acceptable levels for that toxin and 49 times greater than for cadmium.

Both of Oregon's U.S. senators have declared the toxic air a public health emergency.

Chronic exposure to these toxic chemicals can lead to:
* Cancers, including lung, bladder, skin, kidney and liver
* Cardiovascular illnesses
* Lung damage
* Renal dysfunction
* Gastrointestinal damage
* Reproductive dysfunction.

According to news reports, two environmental groups have presented lawmakers with a petition signed by thousands of citizens requesting that the Department of Environmental Quality take appropriate action to see that the quality of the air is improved.

"I can't believe that in this day and age companies would knowingly allow their dangerous chemicals to pollute the air. It's outrageous. We have known for decades the harm these toxic chemicals are capable of causing," stated Erin Brockovich.

The federal Clean Air Act requires metropolitan areas to monitor high levels of certain air pollutants. But this monitoring has not included monitoring for certain dangerous airborne chemical emissions, including arsenic and cadmium.

Long-Term Effects of Glass Company Actions:

"We already know these toxic chemical emissions have contaminated the air and soil. Residents have even been warned not to eat vegetables they've grown in their own gardens," stated Greenwald, who heads Weitz & Luxenberg's Environmental, Toxic Tort & Consumer Protection Unit.

"It is tragic that for months, maybe even decades, these chemicals were causing injury to residents and no one notified the public until now. People in the vicinity of the facility have reported injures directly associated with exposure to these chemicals, and no one knows how many more people might develop illnesses from exposure in years to come," she added.

Weitz & Luxenberg is a long-time advocate for residents, businesses and other property owners who have suffered personal as well as economic injuries resulting from dangerous chemical emissions. Over the years, the law firm has represented many individuals who suffered both personal and economic losses following environmental catastrophes. In addition to affecting health, this type of toxin affects quality of life, as well as the property value of homes and businesses.

One of Weitz & Luxenberg's most recognized cases involved joining other law firms in holding BP accountable for the incalculable health and economic losses following the oil giant's offshore drilling explosion, which spewed millions of gallons of crude oil into the Gulf of Mexico, Greenwald said.

Weitz & Luxenberg, along with other law firms, persuaded BP to enter a financial settlement compensating hundreds of thousands of individuals whose lives and livelihoods were harmed, including residents and oil spill clean-up workers who became sick from exposure to the oil, added Greenwald, who played a key role in the settlement negotiations.

Money May Be Owed to Victims for Health and Property Damage:

Although several of the art-glass companies that may have been responsible for leaching hazardous chemical emissions into the environment have suspended their use of these chemicals, the damage has already been done.

Portland residents who have been affected by the chemical emissions are invited to contact Weitz & Luxenberg for a no-cost, no-obligation evaluation of their legal rights against the parties involved with the toxic chemical emissions.

To obtain the free consultation, chemical emissions victims can reach the law firm toll-free at (800) 476-6070 or online at weitzlux.com.

About Weitz & Luxenberg:

Weitz & Luxenberg P.C. is among the nation's leading and most readily recognized personal injury and consumer protection law firms. Weitz & Luxenberg's numerous litigation areas include: mesothelioma, defective medicine and devices, environmental pollutants, products liability, consumer protection, accidents, personal injury, and medical malpractice. Victims of consumer fraud are invited to rely on Weitz & Luxenberg's more than 25 years of experience handling such cases. You can contact the firm's Client Relations department at 800-476-6070 or at info@weitzlux.com.

More information: http://www.weitzlux.com/.

Twitter: @WeitzLuxenberg

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/erin-brockovich-and-weitz-luxenberg-responding-to-air-quality-issues-in-portland-oregon-2016-0226-01.shtml.

NEWS SOURCE Weitz and Luxenberg P.C. :: This press release was issued on behalf of the news source (who is solely responsible for its accuracy) by and Copr. © 2016 Send2Press® Newswire, a service of Neotrope®.

Paragon BioTeck to Exhibit at American Academy of Ophthalmology Annual Meeting in Chicago

ophthalmic pharmaceuticals

PORTLAND, Ore., Oct. 15, 2014 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in Chicago, Ill., on October 18 - 21.

Visit Paragon BioTeck at booth #4550 to view their product portfolio including the recently FDA cleared medical device Comfortear(R) Lacrisolve(TM) Absorbable Punctum Plug, indicated for medium-term occlusion therapy for up to six (6) months.

The Paragon BioTeck portfolio of products are designed to protect and preserve eyesight and to deliver comfort to the eyes. Other ocular health care products showcased will include the Comfortear(R) Punctum Plug, EqualEyes(TM) Ocular Lubricant, and the preservative-free ilast(R) range of products containing hyaluronic acid (HA) formulated specifically for Eyelid Hygiene.

About Paragon BioTeck, Inc.:

Paragon BioTeck is a privately held ophthalmic-focused biopharmaceutical and medical device company pursuing the development and commercialization of products addressing unmet medical needs in the fight to protect and preserve eyesight.

For more information on the company and its work, please visit http://www.paragonbioteck.com/ or call 888-424-1192; or email info@paragonbioteck.com.

*LOGO: Send2Press.com/mediaboom/14-1015-paragonbio-300dpi.jpg .

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/paragon-bioteck-to-exhibit-at-american-academy-of-ophthalmology-annual-meeting-in-chicago-2014-10-1015-003.shtml.

NEWS SOURCE Paragon BioTeck, Inc. :: This press release was issued on behalf of the news source (who is solely responsible for its accuracy) by and Copr. © 2014 Send2Press® Newswire, a service of Neotrope®.